Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Phalsa (Grewia asiatica) contains concentrated anthocyanins including cyanidin-3-O-glucoside (8-14%) and malvidin-3-O-glucoside that provide potent antioxidant activity through DPPH and FRAP pathway inhibition. These compounds demonstrate significant free radical scavenging capacity and modulate endogenous antioxidant enzymes while exhibiting anti-inflammatory effects via SIRT1 activation.
Reported Benefits (Provisional)
Origin & History
Grewia asiatica, commonly known as Phalsa, is a fruit-bearing shrub native to South Asia, particularly India, Pakistan, and Bangladesh. It thrives in hot, semi-arid to subtropical regions. Traditionally revered in Ayurvedic, Unani, and Siddha medicine, Phalsa is valued for its cooling, immune-enhancing, and antioxidant-rich properties, making it a significant functional food.
Research Narrative (Provisional)
Contemporary scientific studies confirm Phalsa's antioxidant, anti-inflammatory, and cardiometabolic effects, validating its role as a promising functional food. Research supports its ability to improve lipid profiles, regulate blood glucose, and modulate gut microbiota, aligning with its extensive ethnomedicinal documentation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Anthocyanins, flavonoids, tannins, phenolic acids, carotenoids, saponins. - Vitamins: Vitamin C, Vitamin A, Vitamin E. - Minerals: Potassium, Magnesium, Calcium, Phosphorus. - Other: Dietary fiber, natural sugars, digestive enzymes.
Reported Mechanism (Provisional)
Phalsa's anthocyanins, particularly cyanidin-3-O-glucoside and peonidin-3-O-glucoside, exert antioxidant effects by inhibiting DPPH, FRAP, and ABTS free radical markers while modulating endogenous antioxidant enzymes. The phenolic compounds activate SIRT1 pathways involved in metabolic homeostasis and inhibit lipid peroxidation through ROS modulation. Tannins (1.13-2.46% content) and triterpenoids contribute additional antimicrobial activity against Aspergillus species through phenolic fraction mechanisms.
Clinical Narrative (Provisional)
Current evidence consists primarily of preclinical animal and in vitro studies rather than human clinical trials. In mouse studies, phalsa extract at 700 mg/kg body weight significantly decreased brain glutathione and lipid peroxidation levels while demonstrating radioprotective properties. Anticancer research showed methanolic extract increased life expectancy in mice with Ehrlich's ascites carcinoma and inhibited multiple cancer cell lines including K-562 leukemia and MCF-7 breast cancer cells. Clinical validation through human trials remains limited, representing a significant evidence gap for therapeutic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.